Compare Definium Therapeutics Inc. Common Shares (DFTX) vs UBS Group AG Registered Ordinary Shares (UBS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Definium Therapeutics Inc. Common Shares vs UBS Group AG Registered Ordinary Shares — how do they compare? Definium Therapeutics Inc. Common Shares trades at $35.95 (market cap $4.59B), while UBS Group AG Registered Ordinary Shares trades at $47.72 (market cap $142.70B). The key difference: UBS Group AG Registered Ordinary Shares is far larger — about 31.1× Definium Therapeutics Inc. Common Shares's market cap, and UBS Group AG Registered Ordinary Shares pays a 2.34% dividend while Definium Therapeutics Inc. Common Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold Definium Therapeutics Inc. Common Shares for 0 Days and UBS Group AG Registered Ordinary Shares for 0 Days on average.
| DFTX | UBS | |
|---|---|---|
Market Cap | $4.59B | $142.70B |
Volume | 2,103,937 | 2,096,090 |
Sector | Health | Financials |
52-Week High | $48.45 | $55.72 |
52-Week Low | $10.68 | $36.41 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $3.55B | $314.41B |
Dividend Yield | — | 2.34% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Definium Therapeutics Inc. Common Shares
Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.
Read more on DFTX →About UBS Group AG Registered Ordinary Shares
UBS is a global financial services company focused on wealth management, investment banking, and asset management. It serves private, corporate, and institutional clients.
Read more on UBS →
